Protease inhibitor–based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084
Open Access
- 1 April 2007
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 196 (4) , 331.e1-331.e7
- https://doi.org/10.1016/j.ajog.2006.11.037
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of Protease Inhibitor Therapy on Glucose Intolerance in PregnancyObstetrics & Gynecology, 2006
- Assessing the Predictive Accuracy of QUICKI as a Surrogate Index for Insulin Sensitivity Using a Calibration ModelDiabetes, 2005
- Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cellsJournal of Endocrinology, 2004
- Maternal toxicity and pregnancy complications in human immunodeficiency virus–infected women receiving antiretroviral therapy: PACTG 316American Journal of Obstetrics and Gynecology, 2004
- Protease Inhibitors and Decreased Birth Weight in HIV-Infected Pregnant Women With Impaired Glucose ToleranceJournal of Perinatology, 2002
- Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled studyAIDS, 2002
- Lack of an Effect of Protease Inhibitor Use on GlucoseTolerance During PregnancyInfectious Diseases in Obstetrics and Gynecology, 2002
- Disorders of Glucose Metabolism in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2000
- The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor TherapyJournal of Biological Chemistry, 2000
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985